Profilo
Kensaku Akita has worked as a Director at Applizyme, Inc. and as a Manager at Yoshindo, Inc.
Posizioni attive di Kensaku Akita
| Società | Posizione | Inizio |
|---|---|---|
Applizyme, Inc.
 Applizyme, Inc. BiotechnologyHealth Technology Applizyme, Inc. is a holding company that develops deoxygenize activity for polychlorinated biphenyls (PCBs). It develops and offers technologies designed to render harmful substances harmless by using microorganisms and enzymes derived from those microorganisms. The firm’s solutions and technologies detoxify persistent organochlorine compounds, such as PCBs, and provide joint-storage for microbes that have industrial uses. The company was founded on August 10, 2011 and is headquartered in Yonezawa, Japan. | Direttore/Membro del Consiglio | - |
Yoshindo, Inc.
 Yoshindo, Inc. Pharmaceuticals: MajorHealth Technology Yoshindo, Inc. is a pharmaceutical company based in Japan that specializes in producing high-quality generic drugs, essential drugs for infusion and dialysis, and conducting research and development of biopharmaceuticals. The Japanese company aims to become an indispensable player in the pharmaceutical industry in Japan. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Yoshindo, Inc.
Yoshindo, Inc. Pharmaceuticals: MajorHealth Technology Yoshindo, Inc. is a pharmaceutical company based in Japan that specializes in producing high-quality generic drugs, essential drugs for infusion and dialysis, and conducting research and development of biopharmaceuticals. The Japanese company aims to become an indispensable player in the pharmaceutical industry in Japan. | Health Technology |
Applizyme, Inc.
Applizyme, Inc. BiotechnologyHealth Technology Applizyme, Inc. is a holding company that develops deoxygenize activity for polychlorinated biphenyls (PCBs). It develops and offers technologies designed to render harmful substances harmless by using microorganisms and enzymes derived from those microorganisms. The firm’s solutions and technologies detoxify persistent organochlorine compounds, such as PCBs, and provide joint-storage for microbes that have industrial uses. The company was founded on August 10, 2011 and is headquartered in Yonezawa, Japan. | Health Technology |
- Borsa valori
- Insiders
- Kensaku Akita
